Your account is not claimed yet. You can sign up with ORCID to claim your account.

Adrian H M Heagerty (A H M Heagerty, A Heagerty)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Monoclonal Antibody

Diffuse Large B Cell Lymphoma

Intellectual Disability

Top Venues

Clinical and experimental dermatology

The British journal of dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Manrup Kaur Hunjan, Ajoy Bardhan, Natasha Harper, Gerald Langman, Bamidele Ajayi, Vijay Suresh, Adrian H M Heagerty
Successful use of rituximab, an anti-CD20 monoclonal antibody, to treat IgA nephropathy in a patient with recessive dystrophic epidermolysis bullosa. Clinical and experimental dermatology 47 (8) (2022)
Manrup Kaur Hunjan, L Zuzarte, A Bardhan, S Karim, Adrian H M Heagerty
Toxic erythema as the first sign of COVID-19 infection. Clinical and experimental dermatology 46 (4) (2021)
David Wen, Dario Leonardo Balacco, Ajoy Bardhan, N Harper, D Walsh, G Ryan, L Liu, A Guy, John A McGrath, M Ogboli, Adrian H M Heagerty
Localized autosomal recessive epidermolysis bullosa simplex arising from a novel homozygous frameshift mutation in DST (BPAG1). Clinical and experimental dermatology (2021)
Cristina Has, J W Bauer, C Bodemer, M C Bolling, L Bruckner-Tuderman, A Diem, J-D Fine, Adrian H M Heagerty, A Hovnanian, M P Marinkovich, A E Martinez, John A McGrath, Celia Moss, Dedee Frances Murrell, F Palisson, A Schwieger-Briel, E Sprecher, K Tamai, Jouni Uitto, D T Woodley, G Zambruno, Jemima E Mellerio
Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility. The British journal of dermatology 183 (4) (2020)